G9785 – Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG9785
- Long description
- Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
- Short description
- Path report sent
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2017
- Last change
- January 1, 2020 – No change
Frequently asked questions
What is HCPCS code G9785?
G9785 is a HCPCS Level II code for pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist.
Does Medicare cover G9785?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G9777 – Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
- G9778 – Patients who have a diagnosis of pregnancy at any time during the measurement period
- G9779 – Patients who are breastfeeding at any time during the performance period
- G9780 – Patients who have a diagnosis of rhabdomyolysis at any time during the performance period
- G9781 – Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)
- G9782 – History of or active diagnosis of familial hypercholesterolemia
- G9783 – Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy
- G9784 – Pathologists/dermatopathologists providing a second opinion on a biopsy
- G9786 – Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
- G9787 – Patient alive as of the last day of the measurement year
- G9788 – Most recent bp is less than or equal to 130/80 mm hg
- G9789 – Blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits
- G9790 – Most recent bp is greater than 130/80 mm hg, or blood pressure not documented
- G9791 – Most recent tobacco status is tobacco free
- G9792 – Most recent tobacco status is not tobacco free
- G9793 – Patient is currently on a daily aspirin or other antiplatelet
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.